INTRODUCTION
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is generally regarded as a housekeeping glycolytic enzyme. However, several studies implicate GAPDH in cell signaling (Chuang et al., 2005; Hara et al., 2006a; Sirover, 1999 Sirover, , 2005 . We recently described a signaling system influencing cell death whereby diverse cell stressors activate inducible or neuronal nitric oxide synthase (nNOS) leading to the generation of nitric oxide (NO), which S-nitrosylates GAPDH (Benhar and Stamler, 2005; Hara et al., 2005 Hara et al., , 2006a . S-nitrosylation abolishes catalytic activity of the enzyme and confers upon it the ability to bind to Siah, an E3 ubiquitin ligase. The nuclear localization signal of Siah elicits nuclear translocation of GAPDH. In the nucleus, GAPDH binds to the protein acetyltransferase p300/CBP, enhancing its acetylation of various targets, including p53, with subsequent augmentation of cytotoxicity (Sen et al., 2008) .
This signaling cascade appears to mediate the cytoprotective actions of the monoamine oxidase inhibitor R-(À)-deprenyl (selegiline, hereafter designated deprenyl) as well as non-monoamine oxidase inhibiting derivatives (Tatton et al., 2003; Waldmeier et al., 2000) . At low nanomolar concentrations these drugs prevent the S-nitrosylation of GAPDH, its binding to Siah, and nuclear translocation, with neuroprotective actions in cells and rodent models of Parkinsonism at drug doses as low as 0.01 mg/kg (Hara et al., 2006b) . Disruption of the NO-GAPDHSiah cascade also blocks neurotoxicity elicited by excess activation of NMDA (N-methyl-D-aspartate) receptors and mutant Huntingtin (Bae et al., 2006; Hara et al., 2005) .
In the present study, we report a protein interactor of GAPDH, designated GOSPEL (GAPDH's competitor of Siah Protein Enhances Life). Cell stress elicits S-nitrosylation of GOSPEL, enabling it to bind GAPDH in competition with Siah. The binding of GOSPEL to GAPDH prevents nuclear translocation of GAPDH and prevents cyto/neurotoxicity. In intact mice, GOSPEL overexpression in the cerebral cortex reduces NMDA neurotoxicity. This neuroprotection reflects GOSPEL's binding to GAPDH, as mutant GOSPEL that cannot bind GAPDH displays greater neurotoxicity. The competition between GOSPEL and Siah for GAPDH binding may reflect a regulatory system that maintains cellular homeostasis in response to stressors.
RESULTS

Identification of GOSPEL
In a yeast two-hybrid analysis with the N-terminal 150 amino acids of GAPDH and a rat hippocampal cDNA library, we identified 27 positive interactors out of 10 6 clones, 25 of which represented various fragments of GAPDH. This presumably reflects the tendency for this protein to form homotetramers (Carlile et al., 2000) . The two non-GAPDH interactors are a fragment of GOSPEL and an uncharacterized EST clone ( Figure 1A ). By contrast, yeast two-hybrid studies employing the C-terminal 183 amino acids of GAPDH identify Siah, but not GOSPEL (Hara et al., 2005) . After cDNA library screening, we identified the entire coding frame of GOSPEL. GOSPEL contains 406 amino acids with no obvious recognition motifs except for a four amino acid stretch of glutamines (see Figure S1A available online). The intronexon structure of GOSPEL suggests the possibility of alternatively spliced isoforms ( Figure S1B ), although there is high sequence conservation between rodents and humans ( Figure S1C ). Northern blot analysis reveals GOSPEL expression highest in heart, skeletal muscle, brain, and lung ( Figure 1B) . Western blot analysis, employing an affinity-purified polyclonal antibody developed against a recombinant GST-fused GOSPEL, reveals a similar tissue distribution to that shown by northern blotting ( Figure 1C ). In brain, heart, and skeletal muscle, western blots show an apparent molecular weight for GOSPEL of about 52 kDa, whereas in lung the apparent size is somewhat greater, about 55 kDa. Interestingly, tissues such as brain, heart, lung, and skeletal muscle, which are most enriched in GOSPEL, also contain the highest levels of GAPDH. In brain, GOSPEL is widely expressed in neurons, and is especially abundant in neurons that contain high levels of GAPDH, such as Purkinje cells in the cerebellum as well as pyramidal cells of CA1-3 and granule cells of the dentate gyrus in the hippocampus ( Figure 1D) .
We examined the intracellular localization of GOSPEL by immunofluorescent cell staining with confocal microscopy ( Figure 1E ). Overexpressed GOSPEL in HEK293T cells and endogenous GOSPEL in PC12 cells are both predominantly cytosolic.
GOSPEL S-Nitrosylation Is Required for Binding GAPDH We mapped binding sites in GAPDH and GOSPEL by performing selective deletions followed by immunoprecipitation from HEK293 cells (Figures 2A and 2B; Figures S2A and S2B) . We identified amino acids 160-200 of GOSPEL as critical for binding to GAPDH. In GAPDH, a domain comprising amino acids 80-120 is required for binding to GOSPEL.
To determine the importance of S-nitrosylation for the interaction of these proteins, we examined the binding of GOSPEL to GAPDH in extracts of NMDA-treated or untreated cerebral cortical cultures prepared from wild-type or nNOS knockout mice ( Figures 2C and S2C ). It has been demonstrated that NMDA stimulation of cerebral cortical neurons elicits the generation of NO from nNOS, leading to S-nitrosylation of various proteins, including GAPDH (Hara et al., 2005; Takahashi et al., 2007) . A low level of GAPDH-GOSPEL binding is detected in the absence of NMDA treatment. The NMDA-augmented GAPDH-GOSPEL protein interaction is markedly reduced in nNOS knockout cultures. To ascertain whether the requirement for NO involves GOSPEL, we examined whether GOSPEL can be S-nitrosylated. In cerebral cortical cultures stimulated with NMDA, biotin switch assays reveal robust endogenous S-nitrosylation of GOSPEL, which is absent in nNOS knockout cultures ( Figure 2D ). The S-nitrosylation of GOSPEL and GAPDH is time dependent ( Figure 2E ). Following NMDA treatment, S-nitrosylated GOSPEL (SNO-GOSPEL) is detected as early as 3 hr and peaks at 9-16 hr, whereas GAPDH S-nitrosylation is not evident until 6 hr and continues to increase between 9 and 16 hr. We wondered whether the S-nitrosylation of GOSPEL might reflect trans-nitrosylation from GAPDH. This is unlikely, as incubation of S-nitrosylated GAPDH with GOSPEL fails to elicit augmented S-nitrosylation of GOSPEL ( Figure S2D ).
GOSPEL contains a single cysteine at position 47 (C47), which conforms to an S-nitrosylation motif, as the glutamate immediately following C47 resembles the pattern for numerous S-nitrosylated proteins (Kim et al., 1999) including hemoglobin, ras, NMDA receptor, and dynamin. S-nitrosylation of GOSPEL is abolished by replacing the cysteine with serine (GOSPEL-C47S), indicating that this single amino acid is the site for S-nitrosylation of GOSPEL ( Figure 2F ). S-nitrosylation at C47 is crucial for GOSPEL binding to GAPDH, as their binding is greatly reduced for GOSPEL-C47S in HEK293 cells ( Figure 2G ). We have confirmed the importance of S-nitrosylation at C47 for GOSPEL-GAPDH interaction utilizing in vitro binding of the purified proteins ( Figure S3A ). GAPDH S-nitrosylation occurs exclusively on C150 (Hara et al., 2005) . The GAPDH-C150S mutant, which cannot be S-nitrosylated, binds significantly less to GOSPEL than the wild-type protein in HEK293 cells (Figures S3B and S3C) . Therefore, S-nitrosylation of both GAPDH and GOSPEL is crucial for their binding ( Figure 3C ). Of note, GOSPEL, SNO-GOSPEL, and Siah do not influence the catalytic activity of wild-type GAPDH ( Figures S3D and S3E ).
Competition by GOSPEL and Siah for GAPDH Binding Interaction of GAPDH and Siah occurs without S-nitrosylation of Siah, but is augmented by S-nitrosylation of GAPDH. As both Siah and SNO-GOSPEL can bind to S-nitrosylated GAPDH (SNO-GAPDH), we compared the potencies of Siah and SNO-GOSPEL in competing for binding to . SNO-GOSPEL potently inhibits binding of SNO-GAPDH and Siah with an IC 50 of about 10 nM. The inhibition curve is steep, with a decrease of maximal to minimal binding occurring over a 3-fold increase in SNO-GOSPEL concentration. Siah is less potent in inhibiting the binding of SNO-GAPDH and SNO-GOSPEL, with an IC 50 of about 100 nM. The inhibition curve is also steep with maximal to minimal binding evident over a 4-fold increase in Siah concentration. Different portions of GAPDH respectively bind to GOSPEL and Siah ( Figures 1A and 2B ). To determine whether GOSPEL and Siah nonetheless compete for binding to GAPDH, we overexpressed GOSPEL, Siah, and GAPDH in HEK293 cells ( Figure 3C ). Overexpression of GOSPEL markedly diminishes the binding of GAPDH to Siah in the presence of the NO-donor GSNO. Moreover, purified GST-GOSPEL blocks protein interactions of GAPDH and His-Siah in the presence of GSNO ( Figure S4 ).
NMDA also enhances GAPDH-GOSPEL interactions more rapidly than GAPDH-Siah binding ( Figure 3D ). GAPDH-GOSPEL binding is detectable under basal conditions, with increases evident by 3 hr after NMDA. By contrast, GAPDH-Siah binding is absent basally and is not detected until 9 hr after NMDA. The differential kinetics of GAPDH-GOSPEL binding from GAPDH-Siah binding may reflect more rapid S-nitrosylation of GOSPEL (required for GAPDH-GOSPEL binding) than of GAPDH (required for GAPDH-Siah binding) ( Figure 2E ).
GOSPEL Prevents the Nuclear Translocation of GAPDH
To ascertain whether endogenous GOSPEL modulates GAPDHSiah interactions, we depleted endogenous GOSPEL from primary neuronal cultures of cerebral cortex utilizing RNA interference (RNAi) conveyed by a lentivirus. To rule out the possibility of ''off-target'' effects of RNAi, we carried out quantitative realtime PCR for 2 0 5 0 -oligoadenylate synthetase (OAS1), which monitors such off-target effects ( Figure S5A ). The control and GOSPEL RNAi treatment has no influence on the levels of OAS1 mRNA. Furthermore, such RNAi treatment does not affect the levels of nNOS and NO generated in response to NMDA treatment in neurons ( Figures S5B-S5D ). The RNAi to GOSPEL reduces the endogenous protein level by 90% (Figures S6A and S6B) . NMDA-elicited GAPDH-Siah binding is markedly augmented in GOSPEL depleted cultures, establishing that GOSPEL inhibits this interaction ( Figure 4A ).
Because Siah mediates nuclear translocation of GAPDH, we wondered whether GOSPEL prevents such translocation and retains GAPDH in the cytosol. Treatment of HEK293 cells with GSNO, as previously reported, leads to substantial accumulation of GAPDH in the nucleus (Hara et al., 2005) . Overexpression of GOSPEL diminishes the nuclear localization of GAPDH ( Figure 4B ). Endogenous GOSPEL also regulates the NMDA-elicited nuclear translocation of GAPDH, as depletion of GOSPEL by RNAi markedly enhances nuclear GAPDH levels in neuronal cultures ( Figures 4C and S6C) . (E) Time course for S-nitrosylation of GOSPEL and GAPDH following NMDA treatment in primary granule neurons over 16 hr. GOSPEL is S-nitrosylated earlier than GAPDH. S-nitrosylation of GAPDH and GOSPEL were detected by biotin switch assay.
(F) Requirement of cysteine 47 (C47) for S-nitrosylation of GOSPEL. HEK293 cells were transfected with either HA-GOSPEL or HA-GOSPEL-C47S mutant. Cells were then treated with GSH or GSNO for 16 hr and subjected to biotin switch assay. The C47S mutant of GOSPEL is not S-nitrosylated.
(G) Requirement of cysteine 47 (C47) for efficient binding of GOSPEL and GAPDH. HEK293 cells were transfected with myc-GAPDH along with HA-GOSPEL or HA-GOSPEL-C47S, and treated with either GSH or GSNO for 16 hr. The protein interaction was examined by coimmunoprecipitation.
GOSPEL Diminishes NMDA Neurotoxicity by Preventing GAPDH-Siah Binding
We previously demonstrated that NMDA stimulation of cerebellar granule neurons elicits NO generation from nNOS and S-nitrosylation of GAPDH, which translocates to the nucleus together with Siah and elicits neurotoxicity (Hara et al., 2005 (Hara et al., , 2006b ).
We wondered whether the prevention of GAPDH-Siah binding by GOSPEL impacts such neurotoxicity. Accordingly, we examined neurotoxicity in primary cerebellar granule neurons following NMDA treatment ( Figure 5A ). Overexpression of GOSPEL almost completely prevents the 75% decrease in neuronal viability elicited by NMDA treatment. Deletion of the N-terminal 200 amino acids of GOSPEL (GOSPEL-DN200), which prevents binding to GAPDH, abrogates the protective effect of GOSPEL. By contrast, deleting the N-terminal 160 amino acids (GOSPEL-DN160), which does not impair GOSPEL-GAPDH binding, preserves the protective actions of GOSPEL. S-nitrosylation of GOSPEL, which is crucial for binding to GAPDH, is also required for the neuroprotective actions of GOSPEL. Thus, GOSPEL-C47S, which cannot be S-nitrosylated and which does not bind to GAPDH robustly, fails to exert a strong neuroprotective action.
To determine whether endogenous GOSPEL influences neurotoxicity, we employed lentivirus-mediated RNAi to deplete endogenous GOSPEL in primary cerebellar granular cells and cortical neurons. In both cell types we examined, NMDA-nNOS B C A Figure 4 . GOSPEL-GAPDH Binding Prevents GAPDH-Siah Interaction (A) GOSPEL depletion augments GAPDH-Siah binding in primary neuronal cultures after NMDA exposure. Neuron extracts were immunoprecipitated with anti-Siah antibody, and immunoprecipitates were analyzed with SDS-PAGE followed by western blotting with anti-GAPDH antibody. (B) Blockade of GAPDH nuclear translocation by GOSPEL. HEK293 cells were transfected with mock or HA-GOSPEL constructs followed by treatment with 200 mM GSNO for 16 hr, and immunostained with anti-HA (GOSPEL) and anti-GAPDH antibodies. Representative confocal images are shown. Red, GAPDH; green, HA (GOSPEL); blue, DAPI for nucleus. The scale bar represents 40 mm. (C) GOSPEL depletion enhances nuclear GAPDH levels in primary neuronal cultures after NMDA exposure. Neurons were separated into cytosolic and nuclear fractions. Nuclear GAPDH levels were increased in GOSPEL RNAi-treated cells. Anti-histone H2B and anti-actin antibodies were used as nuclear and cytosolic markers, respectively. triggered excitotoxicity, a widely employed model of neurotoxicity (Bonfoco et al., 1995; Dawson et al., 1996) in which GAPDH-Siah is a mediator (Hara et al., 2005 (Hara et al., , 2006b ). Both at 12 and 24 hr following NMDA treatment, cell survival is substantially reduced in GOSPEL depleted cultures (Figures 5B and 5C ; Figures S7A and S7B ).
GOSPEL Is Neuroprotective in Intact Mice
Earlier we demonstrated that treatment with the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) augments the binding of GAPDH to Siah in mouse corpus striatum (Hara et al., 2006b; Sen et al., 2008) . Utilizing a similar paradigm, we show that MPTP treatment stimulates striatal S-nitrosylation of both GAPDH and GOSPEL ( Figure S8A ). MPTP treatment also stimulates the binding of GAPDH-GOSPEL as well as GAPDHSiah, with the increased interaction of GAPDH-GOSPEL occurring earlier than that of GAPDH-Siah ( Figure S8B ).
To determine whether neuroprotective actions of GOSPEL are evident in intact mice, we utilized a viral vector system that delivers into the cerebral cortex wild-type GOSPEL and GOSPEL lacking the N-terminal 200 amino acids (GOSPEL-DN200, which does not bind GAPDH). The two GOSPEL constructs display similar levels of expression in the cerebral cortex monitored by western blotting ( Figure 6A ) and immunohistochemical staining ( Figure 6B ). Neurotoxicity was elicited by direct injection of NMDA into the cerebral cortex ( Figures 6C and 6D ). NMDAinduced lesions in brains of GOSPEL-overexpressed mice are about 30% smaller than in those injected with GOSPEL-DN200. Thus, GOSPEL overexpression in the cerebral cortex leads to selective diminution of NMDA neurotoxicity in vivo. The neuroprotective influence of GOSPEL is attributable to its binding to GAPDH, as a mutant GOSPEL which does not bind GAPDH displays diminished neuroprotective action.
DISCUSSION
In this study we report a protein, GOSPEL, which physiologically binds GAPDH. S-nitrosylation of GOSPEL augments GAPDH-GOSPEL binding, which competes with the interaction of GAPDH with Siah. This competition prevents the nuclear translocation of GAPDH and associated neurotoxicity ( Figure S9 ). GOSPEL is a hydrophilic protein that contains 406 amino acids and appears to be exclusively cytosolic. It lacks obvious functional motifs such as nuclear export and import signals. GOSPEL mRNA and protein levels are highest in organs most enriched in GAPDH, such as brain, heart, lung, and skeletal muscle. This is consistent with the notion that GOSPEL physiologically modulates GAPDH functions. By contrast, Siah levels are similar in all organs examined. GOSPEL retains GAPDH in cytosol, as its depletion augments the nuclear translocation of GAPDH that is associated with cell stress. GOSPEL's neuroprotective actions are robust, as the 75% reduction in viability of cortical neurons elicited by NMDA is reversed by overexpression of GOSPEL in a fashion indicating that its neuroprotective actions derive from its binding GAPDH. In turn, depletion of GOSPEL increases NMDA neurotoxicity.
S-nitrosylation in response to NMDA occurs more rapidly for GOSPEL than GAPDH. Conceivably, this is relevant to the dynamics of cellular responses to nitrosative stress. Thus, perhaps a more rapid initiation of cytoprotective (GOSPEL S-nitrosylation) than cytotoxic (GAPDH S-nitrosylation) mechanisms reflects the cell's approach to coping with nitrosative stress. The more rapid response of GOSPEL to NO suggests that it may have physiologic as well as pathophysiologic functions.
Deprenyl and related neuroprotective drugs very potently prevent GAPDH S-nitrosylation and its binding to Siah (Hara et al., 2006b) . We speculate that GOSPEL and deprenyl act at similar sites on GAPDH. Thus, GOSPEL binds to amino acids 80-120 of GAPDH, which contains the Rossmann fold (Nagy and Rigby, 1995) . The blockade of GAPDH-Siah binding by deprenyl in vitro requires the presence of NAD + , which physiologically interacts with the Rossmann fold (M.R.H., A.S., and S.H.S., unpublished data). These observations raise the possibility that drugs mimicking GOSPEL might exert neuroprotective actions similar to those of deprenyl.
Heretofore, studies of the NO-GAPDH-Siah/GOSPEL cascade have focused upon cyto/neurotoxicity. However, it is likely that this signaling system possesses physiologic roles. Thus, GAPDH-GOSPEL binding is detectable in untreated cerebral cortical cultures with the binding diminished in nNOS depleted cultures or cultures treated with the NMDA antagonist MK801 (data not shown). Nuclear translocation of GAPDH may convey signals from neuronal activity to epigenetic controls of gene transcription by modulating p300/CBP-mediated histone acetylation (Sen et al., 2008) , which may be regulated by GAPDH-GOSPEL interactions.
EXPERIMENTAL PROCEDURES
Unless otherwise noted, all data are representative of three individual experiments.
Chemicals, Antibodies, Plasmids, Overexpression, and RNAi Virus Unless otherwise noted, chemicals were purchased from Sigma. Protein G and A agaroses were purchased from Oncogene. Antibodies were obtained from the following companies: anti-GAPDH monoclonal antibody from Biogenesis; anti-histone H2B antibody and anti-actin antibody from Upstate; anti-HA antibody from Babco; anti-Myc antibody from Calbiochem; anti-nNOS antibody from BD Pharmingen; anti-HA antibody from Covance; anti-Siah antibody from Santa Cruz; and anti-GFP antibody, anti-mouse Ig conjugated to FITC, and anti-rabbit Ig conjugated to rhodamine from Molecular Probes. Polyclonal antibody against GOSPEL was generated with the following procedures: GSTtagged GOSPEL was produced in Escherichia coli, purified through glutathione Sepharose beads (Pharmacia Biotech), and used for antigen. Antisera were produced by a service of Research Genetics, and the sera were immunopurified. Constructs expressing site-directed or deletion mutant proteins were prepared according to the published protocol (Ho et al., 1989) .
GOSPEL RNAi mediated by a lentiviral system (target sequence: 5 0 -AAGGCTCTGATTGAGCAGAAG-3 0 ) was generated as follows: the target sequences were cloned in the pFUGW vector, and this construct was transfected in HEK293FT cells along with two other helper/packaging vectors (D8.9 and VSVg constructs) to produce lentiviral particles. For the production of control lentivirus, FUGW vector was transfected into HEK293FT cells along with two other helper/packaging constructs. Viral production was allowed to take place for 48-72 hr inside HEK293FT cells, and the supernatant was collected and ultracentrifuged to bring down viral particles, which were resuspended in OPTI-MEM. About 10 6 -10 7 pfu/ml viruses was infected in primary neurons for 24 hr. Viral expression was confirmed by observing GFP encoded in pFUGW backbone 5 days after infection. Wild-type HA-GOSPEL and HA-GOSPEL-DN200 expression by a lentiviral system was prepared as follows: both inserts were cloned in pENTR/D-TOPO vector (Invitrogen), and then inserted in pLenti4/TO/V5-DEST vector (Invitrogen) individually by homologous recombination (according to the manufacturer's protocol). The final constructs were transfected in HEK293T cells along with two other helper/ packaging vectors (D8.9 and VSVg constructs), and the supernatant was collected and ultracentrifuged to bring down viral particles, which were resuspended in OPTI-MEM. About 10 7 -10 8 pfu/ml viruses was infected in primary neurons for 24 hr. Viral expression was confirmed by western blotting with an HA antibody 5 days after infection.
Yeast Two-Hybrid and cDNA Library Screenings
The N-terminal amino acids 1-150 of rat GAPDH open reading frame were cloned into yeast expression vector pPC97 containing the Gal4 DNA binding domain. These constructs were used for the screening of a rat hippocampal cDNA library cloned into pPC86 containing the Gal4 transactivation domain. An adult rat brain cDNA library in l ZAPII vector (Stratagene) was screened using the yeast two-hybrid fragment for a portion of GOSPEL open reading frame, labeled with [ 32 P]dCTP using a random priming DNA-labeling kit (Boehringer Mannheim). A total of 1 3 10 6 clones was screened, yielding 61 overlapping clones.
Northern Blotting and In Situ Hybridization
Rat GOSPEL cDNA fragment utilized as a probe was labeled with [ 32 P]dCTP using the High Prime DNA-labeling system (Roche Diagnostics), and northern hybridization was performed at 68 C for 2 hr in QuikHyb solution (Stratagene) with a tissue mRNA blot membrane (Clontech) (Burnett et al., 1998) .
Biochemical Studies
In vitro binding experiments were performed according to the published protocol with glutathione Sepharose (Bae et al., 2005; Kamiya et al., 2005) . Coimmunoprecipitation and western blotting were conducted as published previously (Bae et al., 2005; Kamiya et al., 2005) . Subcellular fractionation was carried out with a nuclear/cytosol fractionation kit (BioVision). An S-nitrosylation biotin switch assay was conducted as published previously (Forrester et al., 2007; Jaffrey and Snyder, 2001 ). Trans-nitrosylation assay was performed as follows: purified wild-type GAPDH (1.5 mg) purchased from Sigma was incubated with 200 mM GSNO at 37 C for 1 hr. The whole reaction mixture was then passed through a desalting column (Pierce) to remove free GSNO. S-nitrosylation of GAPDH was confirmed by biotin switch assay. For the trans-nitrosylation reaction, 0.1, 1.0, or 2.5 mg of GST-GOSPEL was incubated with S-nitrosylated GAPDH at 4 C for 1 hr with mild rotation in 1 ml of buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 0.1 mg/ml BSA, and 0.1% CHAPS). The whole solution was used for the biotin switch assay to detect S-nitrosylation of GOSPEL protein.
In a cell-free binding assay, we purified GAPDH, GOSPEL, and Siah protein separately. GAPDH and GOSPEL were incubated separately with 200 mM GSNO at 37 C for 1 hr. The whole reaction mixture was then passed through a desalting column (Pierce) to remove free GSNO. Then SNO-GAPDH and SNO-GOSPEL were mixed at a 1:1 molar ratio. GST-Siah was added in a concentration-dependent manner (0-500 nM) and kept at 37 C for 1 hr. In another set of experiments, we incubated SNO-GADH and Siah along with different concentrations of GST-GOSPEL (0-100 nM) at 37 C for 1 hr. Then we conducted GST pull-down assays and western blots for GAPDH. After measuring the optical density of GAPDH, we calculated IC 50 values for inhibition of binding between GAPDH and GOSPEL by Siah as well as binding between GAPDH and Siah by GOSPEL. For quantitative PCR, total RNA was isolated from granule neurons with the RNeasy mini kit (QIAGEN) and was reversely transcribed with the Omniscript RT kit (QIAGEN). Real-time PCR was performed using SYBR green PCR master mix for OAS1. The primers used for OAS1 amplification are as follows: forward primer for OAS1 is 5 0 -CCATCCTCAAGTGGACAAGAACTG-3 0 ; reverse primer for OAS1 is 5 0 -TTGGGCTTTGGGCACCTTC-3 0 (Bridge et al., 2003) .
Enzymatic Assay for GAPDH GAPDH (10 nM) or S-nitrosylated GAPDH were preincubated with either GOSPEL (100 nM) or Siah (500 nM) at 37 C for 30 min. S-nitrosylated GOSPEL (100 nM) was also preincubated separately with 10 nM GAPDH or S-nitrosylated GAPDH in the presence or absence of Siah at 37 C for 30 min. The assay mixture was added to each tube and the incubation continued at 37 C for 10 min. The assay mixture contained 10 mM sodium pyrophosphate (pH 8.5), 20 mM sodium arsenite, 2 mM NAD + , and 2 mM glyceraldehyde-3-phosphate. Optical density was measured at 340 nm. All values are normalized to control and expressed as arbitrary units.
Cell Culture and Staining HEK293 cells and HEK293FT cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS and 2 mM L-glutamine at 37 C with a 5% CO 2 atmosphere in a humidified incubator. PC12 cells were maintained in DMEM with 10% FBS, 5% horse serum, 2 mM L-glutamine, and 100 U/ml PS in the same environment. Primary cortical neurons were prepared from fetal mice (14 day gestation) derived from wild-type and nNOS knockout mice, and cultured in neurobasal media supplemented with B27, 2 mM L-glutamine, and 100 U/ml PS at 37 C with a 5% CO 2 atmosphere in a humidified incubator.
Cerebellar granule neurons were prepared from neonatal mice and cultured in basal Eagle's medium containing 10% FBS, 25 mM KCl, and 2 mM L-glutamine. Immunocytochemistry using confocal microscopy was performed as described (Sawa et al., 1999) . Confocal microscropy images were obtained using a Zeiss Meta confocal system. For neuron cultures, anti-GFP antibody was used to enhance the signal from transfected cells.
Measurement of NMDA-Induced Neurotoxicity in Primary Neurons
To activate NMDA receptors in neurons, 8-to 10-day-old cultures (DIC 8-10) were treated with Mg 2+ -free Earle's balanced salt solution containing 300 mM NMDA and 5 mM glycine for 10 min. Three days prior to NMDA receptor activation, cerebellar granule neurons were transfected with plasmids as follows: after preincubation of cells with neurobasal media (GIBCO BRL) including B27 for 24 hr from DIV 5, neurons were transfected with 1 mg of GFP construct and a total of 3 mg of varied combinations of plasmids using Lipofectamine 2000. The molar ratio of expression constructs to GFP plasmid was 3:1. Using fluorescent microscopy with a digital camera, we captured images of more than 20 fields per preparation, which were randomly chosen in a blind manner. GFP-positive neurons were tallied in each field and added together to determine the percentage of viable cells compared to control.
Three days prior to NMDA receptor activation, RNAi lentivirus was infected into granule or cortical neurons. Viability of neurons was assayed 12 or 24 hr after exposure to NMDA as follows: cells were washed with PBS and incubated in 1 mg/ml propidium iodide for 10 min (dead cells are stained in red). After extensive washing to remove nonspecifically attached propidium iodide to cell debris by PBS, neurons were then fixed in 4% paraformaldehyde (PFA) in PBS and stained with DAPI to visualize the total cell population. As the majority of neurons were infected, the ratio of propidium iodide-stained cells to DAPI-stained cells was employed to reflect toxicity.
Measurement of Nitric Oxide Species
To measure the reactive nitric oxide level inside cells, we used 4,5-diamino fluorescein diacetate (DAF-FM; Molecular Probes), a cell-permeable derivative of the indicator DAF-2 whose fluorescence reflects the level of endogenous nitric oxide (Choi et al., 2000; Chvanov et al., 2006) . Briefly, neurons were washed once with Hank's balanced salt solution (HBSS) and then loaded with 5 mM DAF-FM in HBSS and incubated at 37 C with a 5% CO 2 atmosphere in a humidified incubator for 60 min. NMDA (300 mM) and glycine (5 mM) were added to the cells and incubated for another 10 min. Cells were washed and harvested in HBSS, and fluorescence was measured in a fluorimeter utilizing excitation at 485 nm and emission at 530 nm. DAF-2 fluorescence was also detected using a laser scanning confocal microscope (Zeiss Meta).
Animals and MPTP Treatment
All experiments were approved and conformed to the guidelines set by the Institutional Animal Care Committee. Eight-week-old male CD1 mice (Jackson Laboratory) were used. Mice received four i.p. injections of MPTP-HCl (20 mg/kg free base; Sigma) in saline at 2 hr intervals and were sacrificed 16 and 24 hr after the first injection (n = 5). Control mice received saline only. In each case the striatum was isolated and used for immunoprecipitation and S-nitrosylation experiments (Hara et al., 2006b ).
Stereotaxic Injection into Intact Mice
Adult male C57BL/6 mice (20-25 g; Charles River) were used for NMDA-mediated cytotoxicity measurement. Animal protocols, approved by the Institutional Animal Care and Use Committee of Johns Hopkins University, were used in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Animal well-being was determined by monitoring weight and rectal temperature before the surgical procedure. Mice were anesthetized with 3.0% isoflurane, maintained with 1.0% isoflurane, and mounted on a stereotaxic frame (Stoelting). The skull was exposed and 5.0 ml (10 7 -10 8 pfu/ml) of viral particles of either full-length GOSPEL (n = 8) or DN200 GOSPEL (n = 9) protein was slowly injected into the cortex (anterior 0.5 mm, lateral 3.5 mm from bregma, and ventral 1.0 mm relative to dura) over a period of 20 min with the help of a 5.0 ml Hamilton syringe, and the needle was left in place for an additional 5 min. Seven days after viral infection, overexpressed full-length GOSPEL or DN200 GOSPEL in coronal sections was detected by western blot and immunohistochemistry with anti-HA antibody (1:200). On day 8, 15 nmol NMDA was slowly injected at the same location with a 1.0 ml Hamilton syringe. After each injection, mice were placed in a thermoregulated chamber maintained at 31 C ± 0.5 C and returned to their cages after full recovery from anesthesia. The rectal temperatures were monitored and maintained at 37.0 C ± 0.5 C during the experimental procedure.
NMDA-Induced Lesion Quantification
At 24 hr post-NMDA injection, mice were trancardially perfused with 0.1 M PBS and fixed with 4% PFA. Brains were harvested and soaked in 4% PFA overnight, and then equilibrated with 30% sucrose. Sequential brain sections of 25 mm obtained on cryostat were stained with cresyl violet to estimate the lesion volume as described previously (Ahmad et al., 2006 (Ahmad et al., , 2007 . One-way ANOVA followed by Tukey's post-hoc analysis was used to calculate the difference between the groups. 
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